See All Slides - tctmd.com

Slides

Presentation TCT 2019

Transcatheter TR Therapies: Lessons Learned From the International TriValve Registry

Presenter: Maurizio Taramasso, MD

September 28, 2019

Presentation TCT 2019

CTO Guidewire and Technique Update: Navigating the Equipment Maze and the Role of Escalation/De-Escalation

Presenter: Masahisa Yamane

September 28, 2019

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

Presentation TCT 2019

Innovative Trial Designs in Device-Based Hypertension Treatment

Presenter: Konstantinos Tsioufis

September 28, 2019

Presentation TCT 2019

Trends in the Use of Mechanical Circulatory Support in the United States: The 2012-2015 National Inpatient Sample

Presenter: Ankur Kalra

September 28, 2019

Presentation TCT 2019

Building a Tricuspid Valve Program: Early Lessons, Challenges, and Opportunities

Presenter: Charles Davidson

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Presentation TCT 2019

Yes, the Goal Should Be Complete Revascularization!

Presenter: Jeffrey Moses

September 28, 2019

Presentation TCT 2019

No, We Should Not Do Procedures Just Because We Can: Show Me the Data!

Presenter: Robert Yeh

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presentation TCT 2019

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presenter: Andrew Sharp

September 28, 2019

Advertisement

Slides

Transcatheter TR Therapies: Lessons Learned From the International TriValve Registry

CTO Guidewire and Technique Update: Navigating the Equipment Maze and the Role of Escalation/De-Escalation

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Innovative Trial Designs in Device-Based Hypertension Treatment

Trends in the Use of Mechanical Circulatory Support in the United States: The 2012-2015 National Inpatient Sample

Building a Tricuspid Valve Program: Early Lessons, Challenges, and Opportunities

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Yes, the Goal Should Be Complete Revascularization!

No, We Should Not Do Procedures Just Because We Can: Show Me the Data!

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content